Alexandra C. Dionne

Alexandra C. Dionne

Auto-generated profile, based on publicly available information

Alexandra C. Dionne

Department of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in The Journal of Physiology
Verified
Journal Article
Closed access
JMJames R. McIntosh
James R. McIntosh
EJEvan F. Joiner
Evan F. Joiner
JGJacob L. Goldberg
Jacob L. Goldberg
PGPhoebe Greenwald
Phoebe Greenwald
ADAlexandra C. Dionne
Alexandra C. Dionne
JCJason B. Carmel
Jason B. Carmel

20 November 2024 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
NLNathan John Lee
Nathan John Lee
LLLawrence G. Lenke
Lawrence G. Lenke
VAVarun Arvind
Varun Arvind
TSTed Shi
Ted Shi
ADAlexandra C. Dionne
Alexandra C. Dionne
FHFthimnir M Hassan
Fthimnir M Hassan
Background: An accurate knowledge of a patient’s risk of cord-level intraoperative neuromonitoring (IONM) data loss is important for an informed decision-making process prior to deformity correction, but no prediction tool currently exists. Methods: A total of 1,106 patients with spinal deformity and 205 perioperative variables were included. A stepwise machine-learning (ML) approach using random forest (RF) analysis and multivariable logistic regression was performed. Patients were randomly allocated to training (75% of patients) and testing (25% of patients) groups. Feature score weights were derived by rounding up the regression coefficients from the multivariable logistic regression model. Variables in the final scoring calculator were automatically selected through the ML process to optimize predictive performance. Results: Eight features were included in the scoring system: sagittal deformity angular ratio (sDAR) of ≥15 (score = 2), type-3 spinal cord shape (score = 2), conus level below L2 (score = 2), cervical upper instrumented vertebra (score = 2), preoperative upright largest thoracic Cobb angle of ≥75° (score = 2), preoperative lower-extremity motor deficit (score = 2), preoperative upright largest thoracic kyphosis of ≥80° (score = 1), and total deformity angular ratio (tDAR) of ≥25 (score = 1). Higher cumulative scores were associated with increased rates of cord-level IONM data loss: patients with a cumulative score of ≤2 had a cord-level IONM data loss rate of 0.9%, whereas those with a score of ≥7 had a loss rate of 86%. When evaluated in the testing group, the scoring system achieved an accuracy of 93%, a sensitivity of 75%, a specificity of 94%, and an AUC (area under the receiver operating characteristic curve) of 0.898. Conclusions: This is the first study to provide an ML-derived preoperative scoring system that predicts cord-level IONM data loss during pediatric and adult spinal deformity surgery with >90% accuracy. Level of Evidence: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.

1 December 2023 in JBJS Reviews
Verified
Journal Article
Closed access
EAEmily Arciero
Emily Arciero
JCJosephine R. Coury
Josephine R. Coury
ADAlexandra Dionne
Alexandra Dionne
JRJustin Reyes
Justin Reyes
JLJoseph M. Lombardi
Joseph M. Lombardi
ZSZeeshan M. Sardar
Zeeshan M. Sardar
» Chronic preoperative opioid use negatively affects outcomes after spine surgery, with increased complications and reoperations, longer hospital stays, decreased return-to-work rates, worse patient-reported outcomes, and a higher risk of continued opioid use postoperatively. » The definition of chronic opioid use is not consistent across studies, and a more specific and consistent definition will aid in stratifying patients and understanding their risk of inferior outcomes. » Preoperative weaning periods and maximum dose thresholds are being established, which may increase the likelihood of achieving a meaningful improvement after surgery, although higher level evidence studies are needed. » Spinal cord stimulators and intrathecal drug delivery devices are increasingly used to manage chronic back pain and are equivalent or perhaps even superior to opioid treatment, although few studies exist examining how patients with these devices do after subsequent spine surgery. » Further investigation is needed to determine whether a true mechanistic explanation exists for spine-related analgesia related to spinal cord stimulators and intrathecal drug delivery devices.